Consent for AstraZeneca HQ and research facility in Cambridge
- Credit: Archant
Planning permission was granted today for pharmaceuticals giant AstraZeneca to build a new global research and development centre and corporate headquarters in Cambridge.
It will be located on the Cambridge Biomedical Campus and will be home to around 2,000 employees when it becomes operational at the end of 2016.
Mene Pangalos, executive vice president for innovative medicines an early development at AstraZeneca, said: “We are very pleased with today’s decision by Cambridge City Council.
“Work is underway to prepare the site on the Cambridge Biomedical Campus and we look forward to beginning construction in the spring.
“Our aim is to create an open, welcoming and vibrant centre that will inspire our teams and partners to push the boundaries of scientific innovation for the benefit of patients.”
You may also want to watch:
The Cambridge site will bring together AstraZeneca’s small molecule and biologics research and development activity, furthering opportunities to exploit the promise of small and large molecule combinations to make innovative medicines.
It will become the company’s largest centre for oncology research, as well as housing scientists focused on cardiovascular and metabolic diseases, respiratory, inflammation and autoimmune diseases and conditions of the central nervous system.
- 1 'Beautiful inside and out': Tragedy as mum dies 48 hours after giving birth
- 2 Ipswich Town reveal full retained list as six first-teamers get extended stays and eight depart
- 3 Armed police box in cars on A12 after men seen 'fighting with swords'
- 4 Town confirm four more exits at end of season
- 5 'The honour of my life' - Chambers' message to Town fans after departure confirmed
- 6 Exit Interview: Farewell to Ipswich Town's most iconic player of the last decade
- 7 Jeffers set for Ipswich Town coaching role
- 8 Search for man after girl, 10, accosted at B&M store in Stowmarket
- 9 Restaurant launches giant cheesecake and cookie company
- 10 Town remain in talks with Edwards over new deal
The site will also be home to a joint research centre, which will see Medical Research Council-supported researchers working side-by-side with AstraZeneca’s high throughput screening group.
Ahead of the new facility, more than 400 AstraZeneca staff have already relocated to interim facilities in Cambridge, at the Melbourn Science Park, Cambridge Science Park and Granta Park. This is in addition to the around 500 staff already located at the company’s MedImmune facility at Granta Park.